Travel chaos isn’t over! IndiGo cancels more than 450 flights even after ‘operational reset’
New Delhi/IBNS: More than 450 IndiGo flights were cancelled on Monday as the airline continued efforts to stabilise operations after nearly a week of severe disruption, according to media reports.
As per India Today, cancellations were widespread across major metro airports. Delhi logged 134 cancellations, followed by Bengaluru (127), Hyderabad (77), Chennai (71) and Jammu (20). Mumbai, Kolkata and Ahmedabad also faced significant service disruptions.
Though Monday’s numbers remain high, cancellations have declined from the 650 flights cancelled on Sunday and the over 1,000 cancellations reported a few days earlier.
FDTL rule rollout triggers meltdown
IndiGo, known for its punctuality and scale, admitted that it failed to adequately prepare for the rollout of the revised Flight Duty Time Limitation (FDTL) norms for pilots, which came into force on November 1.
The new rules impose stricter limits on night flying hours and mandatory weekly rest, forcing airlines to overhaul crew rosters. IndiGo’s inability to realign schedules in time triggered a cascading operational breakdown, leading to crew shortages, massive delays and unprecedented cancellations across its network.
DGCA issues show-cause notice to CEO
In a rare reprimand, the Directorate General of Civil Aviation (DGCA) issued a show-cause notice to IndiGo CEO Pieter Elbers over what it described as an “operational collapse”.
The aviation regulator said the disruptions caused “severe inconvenience, hardship and distress” to passengers nationwide and accused IndiGo of failing to prepare for the new FDTL regime despite being notified months in advance.
The notice states that the airline violated several Civil Aviation Requirements (CARs), failed to comply with Rule 42A of the Aircraft Rules, 1937, and did not extend mandatory assistance to stranded passengers. The DGCA has held the CEO directly responsible for ensuring operational oversight.
Elbers has 24 hours to respond, failing which the matter may be decided ex parte—potentially leading to penalties or operational restrictions.
IndiGo says it is rebuilding trust
Despite the crisis, IndiGo said it has made “early improvements” following a major operational reset. In a video message on Friday, CEO Pieter Elbers apologised to passengers and acknowledged the scale of the disruptions.
The airline claimed that 95 percent of its operations have now been restored and said it is focused on rebuilding the trust of millions of travellers affected by the week-long turmoil.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles

After 8 years of legal drama, Malayalam actor Dileep acquitted in 2017 rape case — what really happened?
Thiruvananthapuram/IBNS: A Kerala court on Monday acquitted Malayalam film actor Dileep in connection with the 2017 abduction and rape of an actress, media reports said.

Nationwide chaos: IndiGo cancels over 450 flights — minister reveals what really went wrong
Civil Aviation Minister Ram Mohan Naidu on Monday attributed IndiGo’s massive service disruption to issues within the airline’s crew rostering and internal planning system, according to media reports.

Race against time! Indian Navy sends four more warships to Cyclone Ditwah-hit Sri Lanka
The Indian Navy deployed four more ships to supply HADR stores to cyclone-affected regions of Sri Lanka as part of Operation Sagar Bandhu.

After 8 years of legal drama, Dileep acquitted in 2017 rape case — what really happened?
Thiruvananthapuram/IBNS: A Kerala court on Monday acquitted Malayalam film actor Dileep in connection with the 2017 abduction and rape of an actress, media reports said.
Latest News

After 8 years of legal drama, Malayalam actor Dileep acquitted in 2017 rape case — what really happened?

Nationwide chaos: IndiGo cancels over 450 flights — minister reveals what really went wrong

Race against time! Indian Navy sends four more warships to Cyclone Ditwah-hit Sri Lanka

Baldness battle may be over: New drug shows stunning results in phase III trial

